Literature DB >> 20103567

Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Damian Houde1, Yucai Peng, Steven A Berkowitz, John R Engen.   

Abstract

Post-translational modifications (PTMs) can have profound effects on protein structure and protein dynamics and thereby can influence protein function. To understand and connect PTM-induced functional differences with any resulting conformational changes, the conformational changes must be detected and localized to specific parts of the protein. We illustrate these principles here with a study of the functional and conformational changes that accompany modifications to a monoclonal immunoglobulin gamma1 (IgG1) antibody. IgG1s are large and heterogeneous proteins capable of incorporating a multiplicity of PTMs both in vivo and in vitro. For many IgG1s, these PTMs can play a critical role in affecting conformation, biological function, and the ability of the antibody to initiate a potential adverse biological response. We investigated the impact of differential galactosylation, methionine oxidation, and fucosylation on solution conformation using hydrogen/deuterium exchange mass spectrometry and probed the effects of IgG1 binding to the FcgammaRIIIa receptor. The results showed that methionine oxidation and galactosylation both impact IgG1 conformation, whereas fucosylation appears to have little or no impact to the conformation. FcgammaRIIIa binding was strongly influenced by both the glycan structure/composition (namely galactose and fucose) and conformational changes that were induced by some of the modifications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103567      PMCID: PMC2938052          DOI: 10.1074/mcp.M900540-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  The structure of a human type III Fcgamma receptor in complex with Fc.

Authors:  S Radaev; S Motyka; W H Fridman; C Sautes-Fridman; P D Sun
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

2.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

Authors:  P Sondermann; R Huber; V Oosthuizen; U Jacob
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

3.  A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors.

Authors:  J Fraser Glickman; Xiang Wu; Robert Mercuri; Chantal Illy; Benjamin R Bowen; Yang He; Matthew Sills
Journal:  J Biomol Screen       Date:  2002-02

4.  Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

Authors:  E O Saphire; P W Parren; R Pantophlet; M B Zwick; G M Morris; P M Rudd; R A Dwek; R L Stanfield; D R Burton; I A Wilson
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

5.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

6.  The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

Authors:  Y Mimura; S Church; R Ghirlando; P R Ashton; S Dong; M Goodall; J Lund; R Jefferis
Journal:  Mol Immunol       Date:  2000 Aug-Sep       Impact factor: 4.407

7.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

Authors:  Y Mimura; P Sondermann; R Ghirlando; J Lund; S P Young; M Goodall; R Jefferis
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

Review 8.  Recognition of immunoglobulins by Fcgamma receptors.

Authors:  Sergei Radaev; Peter Sun
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

9.  Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry.

Authors:  Damian Houde; Joseph Arndt; Wayne Domeier; Steven Berkowitz; John R Engen
Journal:  Anal Chem       Date:  2009-04-01       Impact factor: 6.986

10.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Authors:  S Krapp; Y Mimura; R Jefferis; R Huber; P Sondermann
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

View more
  117 in total

1.  Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Authors:  Austin W Boesch; James H Kappel; Alison E Mahan; Thach H Chu; Andrew R Crowley; Nana Y Osei-Owusu; Galit Alter; Margaret E Ackerman
Journal:  Biotechnol Bioeng       Date:  2018-02-01       Impact factor: 4.530

2.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors:  Damian Houde; Steven A Berkowitz; John R Engen
Journal:  J Pharm Sci       Date:  2010-12-29       Impact factor: 3.534

Review 3.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

4.  Deciphering the Biophysical Effects of Oxidizing Sulfur-Containing Amino Acids in Interferon-beta-1a using MS and HDX-MS.

Authors:  Damian J Houde; George M Bou-Assaf; Steven A Berkowitz
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-13       Impact factor: 3.109

5.  Characterizing Thermal Transitions of IgG with Mass Spectrometry.

Authors:  Christopher J Brown; Daniel W Woodall; Tarick J El-Baba; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-07-30       Impact factor: 3.109

6.  Investigating the Role of Artemin Glycosylation.

Authors:  Qiu Danwen; Christian Code; Chao Quan; Bang-Jin Gong; Joseph Arndt; Blake Pepinsky; Kasper D Rand; Damian Houde
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

Review 7.  Advances in the assessment and control of the effector functions of therapeutic antibodies.

Authors:  Xu-Rong Jiang; An Song; Svetlana Bergelson; Thomas Arroll; Bhavin Parekh; Kimberly May; Shan Chung; Robert Strouse; Anthony Mire-Sluis; Mark Schenerman
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

8.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

9.  Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Richard Y-C Huang; Roxana E Iacob; Stanley R Krystek; Mi Jin; Hui Wei; Li Tao; Tapan K Das; Adrienne A Tymiak; John R Engen; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-15       Impact factor: 3.109

10.  Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.

Authors:  Jayant Arora; Yue Hu; Reza Esfandiary; Hasige A Sathish; Steven M Bishop; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2016-08-25       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.